# Fidelity Management and Research Company: portfolio, investments and team > Fidelity Management and Research Company is a growth equity based in United States. 14 investments on record, latest Oct 2019. Source: https://millionrounds.com/fund/fidelity-management-and-research-company (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Fidelity Management and Research Company Last cheque observed Oct 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Email Quiet Growth equity Series B Series C Series D Developer APIs FinTech Follow Fidelity Management and Research Company and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Ffidelity-management-and-research-company) Cheques on record **0%** of best year **0** **cheques in 12 months**, 14 on record Since the last cheque **2560** days **00** hrs **00** min **00** sec Median round **$275M** Rounds led **0 of 14** Sole investor **1 rounds** Exits **3 from the portfolio** Mostly in **United States, 93%** Pitch Fidelity Management and Research Company ## Fidelity Management and Research Company highlights - 01 14 rounds on record - 02 Mostly Series B and Series C: 58% of its rounds - 03 Sole investor in 1 rounds, median $17M - 04 3 exits from the portfolio ## What they do - **Type:** Growth equity (from a list, unverified) - **Cheque size:** Not stated - **Sectors:** Developer APIs FinTech - **Based in:** Smithfield, United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **14 appearances** - **2019** 1 round - **Oct** **[Nuvation Bio](https://millionrounds.com/company/nuvation-bio)** Series A · US · FinSMEs **$275M** With 11 others - **2015** 7 rounds - **Sept** **[Intellia Therapeutics](https://millionrounds.com/company/intellia-therapeutics)** Series B · US **$70M** With 7 others - **Aug** **[Wave Life Sciences](https://millionrounds.com/company/wave-life-sciences)** Series B · US **$66M** With 6 others - **Aug** **[Honest Co.](https://millionrounds.com/company/honest-co)** Series D · US **$100M** With 4 others - **Aug** **[Ovid Therapeutics](https://millionrounds.com/company/ovid-therapeutics)** Series B · US **$75M** With 7 others - **Aug** **[Editas Medicine](https://millionrounds.com/company/editas-medicine)** Series B · US **$120M** With 14 others - **Jul** **[GenSight Biologics](https://millionrounds.com/company/gensight-biologics)** Series B · FR **$36M** With 8 others - **Jul** **[Afferent Pharmaceuticals](https://millionrounds.com/company/afferent-pharmaceuticals)** Series C · US **$55M** With 5 others - **2013** 2 rounds - **Oct** **[Pinterest](https://millionrounds.com/company/pinterest)** Series E · US · techcrunch.com **$225M** With 5 others - **Oct** **[MongoDB](https://millionrounds.com/company/mongodb)** Series F · US · techcrunch.com **$150M** With 8 others - **2012** 1 round - **Apr** **[KaloBios Pharmaceuticals](https://millionrounds.com/company/kalobios-pharmaceuticals)** Growth · US **$17M** Sole investor - **2011** 1 round - **Feb** **[Zynga](https://millionrounds.com/company/zynga)** Series C · US · techcrunch.com **$490M** With 3 others - **2008** 1 round - **Jan** **[Slide](https://millionrounds.com/company/slide)** Series D · US · bits.blogs.nytimes.com **$50M** With 1 other - **2007** 1 round - **Feb** **[Exit41](https://millionrounds.com/company/exit41)** Venture · US **$7.0M** With 2 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **24 named** AP **Abigail Pierrepont Johnson** Chairman of the Board, Director i Form ADV AR **Alfonso Riviezzo** Elected Manager i Form ADV AV **Anton V Marchuk** Elected Manager i Form ADV BA **Bart Alexander Grenier** President, Head of Asset Management i Form ADV CM **Casey Moore Condron** Head of Sales & Relationship Management, Director i Form ADV CG **Christian Girard Pariseault** Head of Institutional Portfolio Managers, Director i Form ADV CJ **Christopher John Rimmer** Treasurer i Form ADV CM **Christopher Michael Gouveia** Compliance Officer i Form ADV CL **Cynthia Lo Bessette** Senior Vice President, Secretary, Chief Legal Officer i Form ADV DG **Dalton Gustafson** Elected Manager i Form ADV ED **Edward Daniel O'Brien** Elected Manager i Form ADV ES **Erica Steinig Birke** Elected Manager i Form ADV GJ **Gary John Gallagher** Elected Manager/President i Form ADV HJ **Harley Jay Lank** Head of High Income i Form ADV JD **James Darby Nielson** Chief Investment Officer i Form ADV JJ **Jason John Linde** Chief Compliance Officer i Form ADV JP **Jason Philip Pogorelec** Compliance Officer i Form ADV KL **Kimberly Lyn Perry** Director i Form ADV KY **Ksenia Yanovna Portnoy** Compliance Officer i Form ADV MS **Manmohan S Seth** Elected Manager i Form ADV MT **Martin Tague Mcgee** Director i Form ADV PR **Pam Ruddick Holding** Co-Head Equity i Form ADV PS **Peter Simon Lynch** Vice Chairman, Director i Form ADV RS **Richard Scott Harrigan** Chief Financial Officer i Form ADV We also hold **31** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **$7431B** assets it manages, 5 advisers combined Oct 2026 **Registered** investment adviser full reporting to the SEC - **Legal name:** Fidelity Diversifying Solutions LLC - **SEC number:** CRD 104555 Funds on its Form ADV **31** private funds, **$7.0B** in gross assets · filed Nov 2024 Other pooled investment vehi **15** Private equity **7** Hedge **5** - FIAM Global Unconstrained Equity Fund L.P. *Hedge* 78 investors $1.5B - FIAM Broad Market Duration Fund, LLC *Other pooled investment vehi* 6 investors $968M - FIAM Tactical BOND Fund, L.P. *Other pooled investment vehi* 27 investors $490M - FIAM Leveraged LOAN Fund, L.P. *Other pooled investment vehi* 8 investors $392M - FIAM Core Plus Fund, LLC *Other pooled investment vehi* 10 investors $359M - FIAM Select Emerging Markets Equity Fund, L.P. *Other pooled investment vehi* 9 investors $341M - FIAM Global LOW Volatility Equity Fund L.P. *Other pooled investment vehi* 5 investors $303M - Fidelity Real Estate Opportunistic Income Fund L.P. *Hedge* 14 investors $302M - FIAM Select International Equity Fund, LLC *Other pooled investment vehi* 2 investors $285M - Fidelity Evergreen Private Credit Master Fund L.P. *Hedge* 7 investors $276M And 21 more on the filing. ## What they claim to have backed From their own portfolio page (on their website) **1** of 7 we have independently watched raise [Reddit](https://millionrounds.com/company/reddit) About Fidelity Alerts Communications Customer Support Documents FINRA's BrokerCheck Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded. ## Exits from the portfolio Companies it backed that were later bought or listed **3 in all** **[KaloBios Pharmaceuticals](https://millionrounds.com/company/kalobios-pharmaceuticals)** Listed **Undisclosed** Jan 2013 **[Zynga](https://millionrounds.com/company/zynga)** Listed **Undisclosed** Dec 2011 **[Slide](https://millionrounds.com/company/slide)** Bought by [Google](https://millionrounds.com/fund/google-assistant-investments) **$182M** Aug 2010 An exit counts when it came after the firm's first round in the company. From historical deal records. ## The cheque Series B Series C Series D Median round joined **$275M** the round, not its cheque Alone, median **$17M** Led 0 of 14 rounds **0%** - **Sole investor:** 1 rounds - **Last cheque:** Oct 2019 - **Exits:** 3 from the portfolio Rounds by stage said on their site - Series B *5* - Series C *2* - Series D *2* - Series F *1* - Growth *1* - Venture *1* Cheques by year Led Joined 2007 2019 Often in the room with - [Jennison Associates](https://millionrounds.com/fund/jennison-associates) 5 - [Redmile Group](https://millionrounds.com/fund/redmile-group) 4 - [T. Rowe Price](https://millionrounds.com/fund/t-rowe-price) 4 - [EcoR1 Capital](https://millionrounds.com/fund/ecor1-capital) 3 - [Cormorant Asset Management](https://millionrounds.com/fund/cormorant-asset-management) 2 - [Foresite Capital](https://millionrounds.com/fund/forsite-capital) 2 **Pitching Fidelity Management and Research Company?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Fidelity Management and Research Company. A count of rooms they were both in, not a relationship either has claimed. [**Jennison Associates** Growth equity **5** rounds together](https://millionrounds.com/fund/jennison-associates)[**Redmile Group** VC firm **4** rounds together](https://millionrounds.com/fund/redmile-group)[**T. Rowe Price** Private equity **4** rounds together](https://millionrounds.com/fund/t-rowe-price)[**EcoR1 Capital** Private equity **3** rounds together](https://millionrounds.com/fund/ecor1-capital)[**Cormorant Asset Management** Private equity **2** rounds together](https://millionrounds.com/fund/cormorant-asset-management)[**Foresite Capital** Private equity **2** rounds together](https://millionrounds.com/fund/forsite-capital)[**New Leaf Venture Partners** VC firm **2** rounds together](https://millionrounds.com/fund/new-leaf-venture-partners)[**Omega Funds** VC firm **2** rounds together](https://millionrounds.com/fund/omega-funds)[**Perceptive Advisors** Asset manager **2** rounds together](https://millionrounds.com/fund/perceptive-advisors)[**Tekla Capital Management** VC firm **2** rounds together](https://millionrounds.com/fund/tekla-capital-management) ## Recently backed The latest companies Fidelity Management and Research Company put money into. [**Nuvation Bio** $275M · Oct 2019](https://millionrounds.com/company/nuvation-bio) ## Quick answers about Fidelity Management and Research Company ### What does Fidelity Management and Research Company invest in? Fidelity Management and Research Company invests most often at Series B and Series C (58% of the rounds on record), in sectors such as Developer APIs and FinTech. ### How active is Fidelity Management and Research Company? 14 investments on record, 0 of them in the last 12 months. The most recent was in Oct 2019. ### What has Fidelity Management and Research Company invested in recently? Its most recent investments on record: Nuvation Bio (Series A, Oct 2019). ### How big are Fidelity Management and Research Company's cheques? The median round it joins is $275M. ### Does Fidelity Management and Research Company lead rounds? Rarely, if at all: none of its 14 investments on record names it as the lead. ### Where does Fidelity Management and Research Company invest? Most of the companies it backs are in the United States (93%) and France (7%). ### Is Fidelity Management and Research Company investing now? No investments in the last 12 months; the latest was in Oct 2019. ### Who does Fidelity Management and Research Company invest alongside? Most often Jennison Associates (5 rounds together), Redmile Group (4 rounds together) and T. Rowe Price (4 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=fidelity-management-and-research-company) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=fidelity-management-and-research-company)